Objective. Ghrelin, a 28 amino acid peptide, has diverse physiological roles. Phosphatidylinositol-bisphosphate 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) are involved in some of the recognized actions of ghrelin. It has been shown that ghrelin upregulates HOXB4 gene expression but the real mechanism of this effect is not clear.
Ghrelin, a peptide mostly produced in the stomach, is endogenous secretagogues of the growth hormone (Kojima and Kangawa 2005) . The ghrelin receptor named as GHS-R1a, a G protein-coupled receptor, has been cloned in different tissues of the body (Albarran-Zeckler and Smith 2013) . Since its finding, many physiological roles have been attributed to the ghrelin (van der Lely et al. 2004) . During the last decade, its effects on various cell lines including stem cells have been elucidated. A couple of studies have shown the beneficiary effects of ghrelin on neurogenesis (Moon et al. 2009; Li et al. 2013) . Furthermore, some researchers have introduced this peptide as an inducer to provide cardiomyocytes from embryonic stem cells (Yang et al. 2011) .
Recently, we have shown that ghrelin upregulates HOXB4 gene in rat's bone marrow stromal cells (BMSCs) (Abdanipour et al. 2018a) . BMSCs are a population of mesenchymal stem cells, which are widely used in experimental and clinical cell therapy strategies (Mahmood et al. 2004 ). These cells have a high differentiation capability to other cells including bone, cartilage, and adipocytes (Bianco et al. 2001) . BMSCs also support hematopoietic stem cells (HSCs) in bone marrow (Anthony and Link 2014) .
Homeobox (Hox) genes are transcription factors that mainly regulate embryonic development (Svingen and Tonissen 2006) . HOXB4, one of the Hox family genes, mostly is expressed in hematopoietic stem cells (Antonchuk et al. 2002) . Multiple signaling pathways are involved in physiological actions of ghrelin while phosphatidylinositolbisphosphate 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) are among the best understood mediators (Chung et al. 2008; Chung et al. 2013; Yin et al. 2014) . To find out the mechanism of HOXB4 upregulation by ghrelin, the aim of this study was to evaluate the involvement of PI3K and MAPK pathways in this effect of ghrelin.
Material and methods
BMSCs culture and drug treatments. All the experiments were carried out under the ethical guidelines of Zanjan University of Medical Sciences (IR.ZUMS.REC.1396.245). Male Wistar rat of 4-6 weeks were sacrificed under deep anesthesia using ketamine-xylazine (K, 100 mg/kg; X, 10 mg/kg). The lower limbs were removed with a pair of scissors separating it from the hip joint and put on a sterile gauze. The accompanied soft tissue (muscles, fasciae, and tendons) was removed, and femurs and tibiae were separated and put in a dish containing phosphate buffered saline (PBS, Gibco, Life Technologies, USA) and penicillin/streptomycin (Gibco, Life Technologies, USA). The dish was transferred under a laminar hood. The bones were subsequently washed again with PBS and put on a sterile gauze to dry. Both ends of the bones were cut, then with an insulin syringe containing high glucose Dulbecco's Modified Eagle Medium (DMEM, Gibco, Life Technologies, USA) and 1% penicillin/streptomycin, all the contents of the bone's lumen were flushed directly to 25 cm 2 culture flask (SPL, life sciences, Korea) without any additional manipulation. The flushing was done several times, so that the lumen became pale. Rat BMSCs were initially cultivated in DMEM (Dulbecco's Modified Eagle Medium), supplemented with 20% FBS (Gibco), 100 U/ml penicillin, and 100 mg/ml streptomycin in 4 experimental groups as B (untreated BMSCs), BG (BMSCs treated with 100 µM ghrelin), PD (BMSCs treated with 10 µM PD98059 and 100 µM ghrelin) and LY (BMSCs treated with 10 µM LY294002 and 100 µM ghrelin). The cells were incubated at 37 °C (5% CO 2 ) in 25 cm 2 plastic flask. The medium refreshed every 2-3 days until cells became confluent. The cells were harvested with trypsin-EDTA and passaged up to three times. To induce BMSCs, ghrelin (Tocris Bioscience Co., Bristol, UK) was freshly prepared. Passage 3 BMSCs were cultured in 96-well plates (5 000 cells/well) in DMEM medium supplemented with ghrelin 100 μM for 48 h. To assay the effect of kinase inhibitor on HOXB4 gene expression, BMSCs were pretreated with ERK inhibitor PD98059 (10 μM) and PI3K inhibitor LY294002 (10 μM) (Sigma-Aldrich, USA) for 3 h prior to treatment with ghrelin.
Real-time PCR. Real-time PCR was carried out with RNA from Control (untreated BMSCs), BG (BMSCs treated with 100 µM ghrelin), PD (BMSCs treated with 10 µM PD98059) and LY (BMSCs treated with 10 µM LY294002) and Synergic or SY (BMSCs treated with 10 µM LY294002 plus 10 µM PD98059, and 100 µM ghrelin) groups. In all groups, 1000 ng purified RNA from cultured cells was used to synthesize 20 μl cDNA, using Revert aid™ first strand cDNA synthesis kit (Fermentas, Germany) according to the manufacturer's instructions. cDNA (25 ng) was used to quantify HOXB4 mRNA levels. As an internal control, primers for β-actin were used. All primers have been listed in Table 1 . The PCR reaction was synthesized in a 12.5 μl volume (sense and anti-sense primers, cDNA, Sybr green,) and carried out for 40 cycles (Applied Biosystems cycler). For analyzing relative changes in mRNA levels, we used the delta CT method (Pfaffl method).
Immunostaining. BMSCs were cultured on cover slides and fixed in 3% paraformaldehyde for 20 min at RT, followed by a permeabilization step in 100% methanol for 30 min at room temperature (RT). For immunofluorescence, BMSCs were incubated with anti-CD90 monoclonal antibody, followed by incubation with a fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse antibody (Millipore). Nuclei were counterstained with DAPI. For indirect immunoperoxidase labeling, passage 3 rd BMSCs (for 48 h) were permeabilized with 0.4% Triton X-100, followed by FCS 10% for 60 min to block endogenous peroxi- dase. Then BMSCs were incubated with anti-CD90 monoclonal antibodies (dilution 1/100; Abcam) overnight at 4 °C, followed by incubation with a fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse antibody (dilution 1/300, Millipore) for 4 h at RT. Statistical analysis. Relative gene expression changes between cDNA samples were determined using Relative expression software tool 9 (REST 9, Qiagen), in which the β-actin gene was used as internal control. All data were expressed as means ± Standard Error of the Mean (SEM). One-way ANOVA followed by Tukey's post hoc was used to compare multiple means in groups. The level of significance was set at p<0.05.
Results
BMSCs expansion and identification. The primary culture of the isolated BMSCs is presented at Figures 1A, D. The results showed that after 12 h, the cells were attached to the flask and most of them were rounded ( Figure 1A ). Adherent cells were cultured and became heterogeneous after 12 or 16 days (passage 4) ( Figure 1D) . Following, the cells were immunostained with anti-CD90 (mesenchymal stem cells markers) antibody and incubated with FITCconjugated secondary antibody. The result showed that 100% of the cells were immunoreactive to CD90 (Figures 1E, F) . Effect of ghrelin on HOXB4 gene expression rates. The results of the mRNA expression pattern have been shown in the (Figure 2 ). Our data showed that mRNA expressions of HOXB4 gene significantly increased when ghrelin 100 µM was used (BG; 16.39±6.36) as compare to the control group (p<0.05).
Effect of PD98059 and LY294002 on HOXB4 gene expression rates. As presented in Figure 2 , although PD98059 (10 µM) co-treatment with ghrelin (100 µM 
Discussion
Based on the data obtained in the present study, ghrelin upregulated HOXB4 gene expression in BMSCs and PI3K inhibition by LY294002 eliminated the promoting effect of ghrelin on the HOXB4 gene expression. Consequently, this effect of ghrelin on BMSCs could be mediated via the PI3K. We also found that inhibiting MAPK by PD98059 (10 µM) could partially suppress the inducing effect of ghrelin on BMSCs, suggesting that other pathways may be involved in HOXB4 upregulation by ghrelin. In fact, depending on the inducer and/or the used cells the outcomes could be different. For example, it has been shown that thrombopoietin stimulates HOXB4 expression through MAPK pathway. This effect was not abolished by LY294002 and it means that the PI3K was not involved in the phenomenon (Kirito et al. 2003) .
Furthermore, in the present study, there was no synergic effect observed while PD98059 was combined with LY294002, but oppositely PD98059 reversed the inhibitory effect of LY294002 on HOXB4 gene expression. It seems that the crosstalk between ERK and PI3K/Akt pathways leads to opposite regulation of HOXB4 expression in BMSCs. It is notable that according to some findings in the literature, there exists an interaction between MAPK and PI3K pathways and in some cases, they have contrary manners in their actions (Lee et al. 2006; Gan et al. 2010; Hu et al. 2012) .
Several studies have shown that cAMP/PKA, PI3K/Akt and MAPK could be activated by ghrelin (Chung et al. 2008; Chung et al. 2013; Yin et al. 2014) . PI3K/Akt pathway plays an important role in the physiological functions of ghrelin. In hepatoma cells, ghrelin increases insulin receptor substrate (IRS-1) associated PI3K activity and affects glucose transport (Murata et al. 2002) . Moreover, it has been revealed that ghrelin through PI3K signaling controls cognitive aspects of feeding (Kanoski et al. 2013) . It has been shown that PI3K/Akt contributes to the antiapoptotic effects of ghrelin in cardiomyocytes and primary cultured rat neuronal cells (Baldanzi et al. 2002; Chung et al. 2011 ). Ghrelin has also been shown to inhibits the apoptosis of the adipose-derived mesenchymal stem cells (ADMSCs) both in vitro and engrafted in ischemic heart through PI3K/Akt pathway .
BMSCs, as a source of mesenchymal stem cells, are used in cell therapy (Hu et al. 2008; Bi et al. 2015) . However, they may suffer during transplantation due to oxidative stress before accommodation to new condition (Potier et al. 2007 ). Previously, we have shown that ghrelin improves BMSCs survival through regulating the Bcl2 and Caspase3 gene expression in vitro (Abdanipour et al. 2017; Abdanipour et al. 2018b ). Accordingly, PI3K/Akt signaling could be the possible mechanism of the ghrelin's effect on BMSCs proliferation and apoptosis.
Some research groups have indicated that overexpression of HOXB4 inhibits apoptotic cell death especially in hematopoietic cells (Antonchuk et al. 2001; Daniels et al. 2010; Park et al. 2012) . Regarding to our previous findings, part of the anti-apoptotic effect of ghrelin in BMSCs could be due to HOXB4 overexpression in these cells. Another remarkable fact is that HoxB4 upregulation in embryonic stem cells could differentiate them to HSCs (Thorsteinsdottir et al. 1999; Lee et al. 2008; Jackson et al. 2012; Forrester and Jackson 2012) . Whether HOXB4 overexpression by ghrelin also may contribute to the probable BMSCs differentiation to HSCs requires further research.
Taken together, we can conclude that ghrelin, through PI3K/Akt pathway may improve the BMSC transplantation potency by reducing its apoptosis. Moreover, upregulating HOXB4 in BMSC and its possible differentiation to HSCs, which needs to be proven by further investigations, could open the doors to new treatment for hematologic disorders. Therefore, activating the PI3K/Akt pathway, instead of using a non-specific inducer, could be the principal point to increase the efficiency of BMSC-based cell therapies in the future.
In conclusion, ghrelin upregulates HOXB4 gene expression in rat's BMSCs through PI3-kinase signaling pathway.
